The Evaluate Vantage team are back from the 2023 ASCO Annual Meeting in Chicago, where we've been reporting on all the big data drops and breakthroughs in cancer care.

To keep you up to speed on all the important developments and share our analysis of their likely market impact, we've rounded up all our ASCO 2023 stories into one eBook.


Regeneron nips at Bristol's heels in Lag3
Commands leaves the door open for Geron
Preview - A microcap winner
Preview - Tigit lives again
Novartis's adjuvant breast cancer win comes with caveats
And more